Psychopharmacology
Psychopharmacology explores the use of medications to treat mental health disorders. From antidepressants to antipsychotics, understanding the mechanisms, efficacy, and side effects of these drugs is crucial. The Journal of Clinical Psychiatry offers in-depth insights into psychopharmacological treatments, their applications, and the latest research. Our expert editors curate content that is evidence-based and clinically relevant, ensuring psychiatrists are well-informed about the latest developments in medication-based treatments.
The Weekly Mind Reader: The Power of Meta-Analysis
A clear explanation of meta-analysis to help clinicians read, understand, and process the importance of the research they read.
The Top JCP Psychiatry Research of 2023
The Journal of Clinical Psychiatry's top 10 articles of 2023 highlighted innovative mental health treatments and insights.
The Weekly Mind Reader: Semaglutide In Alcohol Use Disorder Treatment
Semaglutide, known for its effectiveness in obesity treatment, shows promise in reducing symptoms of alcohol use disorder.
Recent JCP Articles
How to Use Percentiles to Better Understand Standardized Mean Difference (SMD) as a Measure of Effect Size
Chittaranjan Andrade, MD, explains the use of SMDs as a measure of effect size. A recent meta-analysis of the effect of ChEIs on hallucinations and delusions in Alzheimer and Parkinson disease is used as an example.
Cholinesterase Inhibitors for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Questionably Significant Benefits
Chittaranjan Andrade, MD, takes a closer look at a recent meta-analysis indicating that donepezil, rivastigmine, and galantamine lessened both delusions and hallucinations in Alzheimer disease and Parkinson disease.
Understanding Misunderstandings About the Relative Risk and Odds Ratio
Using simple concepts and arithmetic, Chittaranjan Andrade, MD, teaches readers how to derive and interpret relative risk and odds ratios.
Recent PCC Articles
Antidepressants–A Misnomer? Clinical Impressionism or Scientific Empiricism?
In this brief report, the authors discuss the many clinical indications of antidepressants.
Drug-Related Problems Following Use of Clonazepam Oral Drops
Drug-related problems associated with clonazepam oral drops have been reported to local postmarketing surveillance services recently. Here, the authors present an investigation to determine if such events were associated with product quality deviation.
Transdermal Psychotropic Agents: “Aye” or “Nay”?
In this brief report, Dr Naguy provides an overview of transdermal psychotropic medications.
Front of Mind News
The Weekly Mind Reader: WHO Updates Key Mental Health Guidelines
The updated WHO mhGAP guideline offers vital recommendations for treating mental and neurological disorders.
How 'Publication Bias' May Skew Our Understanding of Xanax Efficacy
A recent study questions the true efficacy of the anti-anxiety drug Xanax in panic disorder due to publication bias.
The Weekly Mind Reader: Topiramate's Potential Role in PTSD Treatment
An investigation finds mixed results for the efficacy of the anticonvulsant agent topiramate in the treatment of civilian PTSD.
Why Antidepressants May Take Weeks to Show Benefits
A new study adds a valuable piece to the puzzle of how SSRIs work, and why It often takes several weeks for their effects to be felt.
The Weekly Mind Reader: A Potential New ADHD Treatment
An online study found solriamfetol significantly improved ADHD symptoms in adults and had a good safety profile.